QuidelOrtho Corporation

Equities

QDEL

US2197981051

Market Closed - Nasdaq Other stock markets 21:00:00 17/06/2025 BST			5-day change	1st Jan Change
28.03 ^USD	-4.07%		-7.22%	-37.08%

06-05	QuidelOrtho Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 08:45 AM
06-04	QuidelOrtho Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-04-2025 08:00 AM

QuidelOrtho Corporation, Q2 2024 Earnings Call, Jul 31, 2024

Published on 31/07/2024 at 22:00

Presentation Operator Message
Operator (Operator)

Welcome to the QuidelOrtho Second Quarter 2024 Financial Results Conference Call and Webcast. [Operator Instructions] Please note this conference call

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about QuidelOrtho Corporation

QuidelOrtho Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 08:45 AM	06-05
QuidelOrtho Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-04-2025 08:00 AM	06-04
QuidelOrtho Corporation - Special Call	06-04
QuidelOrtho Plans to Acquire LEX Diagnostics for $100 Million, Discontinue Savanna Platform	06-03	MT
QuidelOrtho Corporation intent to acquire remanining majority stake in Lex Diagnostics Limited from TTP Group plc for approximately $100 million.	06-02	CI
Sector Update: Health Care Stocks Decline Thursday Afternoon	05-08	MT
QuidelOrtho Shares Gain After Q1 Adjusted Earnings Beat Consensus	05-08	MT
UBS Cuts Price Target on QuidelOrtho to $29 From $45, Keeps Neutral Rating	05-08	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Hopes of Potential US-UK Accord	05-08	MT
QuidelOrtho Q1 Adjusted Earnings Rise, Revenue Falls; Fiscal 2025 Guidance Maintained	05-08	MT
QuidelOrtho Corporation, Q1 2025 Earnings Call, May 07, 2025	05-07
(QDEL) QUIDELORTHO CORPORATION Sees Fiscal Year 2025 Adjusted EPS Range $2.07 - $2.57	05-07	MT
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Reports Q1 Revenue $692.8M, vs. FactSet Est of $689.6M	05-07	MT
(QDEL) QUIDELORTHO CORPORATION Forecasts Fiscal Year 2025 Adjusted EPS Range $2.07 - $2.57	05-07	MT
(QDEL) QUIDELORTHO CORPORATION Sees Q2 Adjusted EPS Range $2.07 - $2.57	05-07	MT
QuidelOrtho Corporation Maintains Earnings Guidance for the Full Year 2025	05-07	CI
QuidelOrtho Corporation Reports Earnings Results for the First Quarter Ended March 30, 2025	05-07	CI
QuidelOrtho Corporation Introduces Results Manager? System	03-10	CI
QuidelOrtho Corporation Presents at Raymond James & Associates? 46th Annual Institutional Investors Conference 2025, Mar-05-2025 08:40 AM	03-05
UBS Raises Price Target on QuidelOrtho to $45 From $43, Maintains Neutral Rating	02-13	MT
RBC Trims Price Target on QuidelOrtho to $61 From $64, Keeps Outperform Rating	02-13	MT
QuidelOrtho Q4 Adjusted Earnings, Revenue Decline; 2025 Guidance Issued	02-12	MT
QuidelOrtho Corporation, Q4 2024 Earnings Call, Feb 12, 2025	02-12
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Reports Q4 Adjusted EPS $0.63, vs. FactSet Est of $0.59	02-12	MT
Earnings Flash (QDEL) QUIDELORTHO CORPORATION Reports Q4 Revenue $708M, vs. FactSet Est of $699.2M	02-12	MT